Tag Archives | take-back

JNJ

JNJ: Proxy Score 53

JNJ, Johnson&Johnson (NYSE: $JNJ) researches, develops, manufactures, and sells various products in the health care field worldwide through three segments: Consumer, Pharmaceutical, and Medical Devices. It is one of the stocks in my portfolio. Their annual meeting is coming up on April 28, 2016. ProxyDemocracy.org had collected the votes of two funds when I checked. I voted AGAINST the pay plan, […]

Continue Reading ·

Powered by WordPress. Designed by WooThemes